Edition:
United States

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

216.22USD
2:35pm EDT
Change (% chg)

$-0.77 (-0.35%)
Prev Close
$216.99
Open
$217.86
Day's High
$218.42
Day's Low
$215.80
Volume
255,326
Avg. Vol
422,720
52-wk High
$226.34
52-wk Low
$153.86

Latest Key Developments (Source: Significant Developments)

Thermo Fisher Scientific CEO Marc Casper's FY 2017 Total Compenstion Was $22.3 Mln VS $17.8 Mln
Tuesday, 10 Apr 2018 08:40am EDT 

April 10 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC CEO MARC N. CASPER'S FY 2017 TOTAL COMPENSTION WAS $22.3 MLN VS $17.8 MLN - SEC FILING.  Full Article

Ortho Clinical Diagnostics And Thermo Fisher Scientific Agree To Deliver 14 Assays For Use On Ortho's Vitros Systems
Thursday, 5 Apr 2018 08:50am EDT 

April 5 (Reuters) - Thermo Fisher Scientific Inc ::ORTHO CLINICAL DIAGNOSTICS AND THERMO FISHER SCIENTIFIC AGREE TO DELIVER 14 ASSAYS FOR USE ON ORTHO'S VITROS® SYSTEMS.ORTHO CLINICAL DIAGNOSTICS SAYS ASSAYS WILL INITIALLY BE LAUNCHED IN NORTH AMERICA, EUROPE, AFRICA AND MIDDLE EAST.  Full Article

Biocept And Thermo Fisher Scientific Enter Into Technology And Commercial Collaboration
Wednesday, 28 Mar 2018 08:05am EDT 

March 28 (Reuters) - Biocept Inc ::BIOCEPT AND THERMO FISHER SCIENTIFIC ENTER INTO TECHNOLOGY AND COMMERCIAL COLLABORATION.BIOCEPT INC - ENTERED INTO A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH THERMO FISHER SCIENTIFIC, INC. TO COLLABORATE TOGETHER COMMERCIALLY​.BIOCEPT - P‍LAN TO VALIDATE THERMO FISHER'S ONCOMINE NEXT-GENERATION SEQUENCING LIQUID BIOPSY PANELS IN BIOCEPT'S CLIA-CERTIFIED LABORATORY​.  Full Article

Thermo Fisher Scientific Acquires Integenx
Friday, 16 Mar 2018 06:23pm EDT 

March 16 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC ACQUIRES INTEGENX, PROVIDER OF LEADING RAPID DNA TECHNOLOGY FOR HUMAN IDENTIFICATION.ANNOUNCED THAT IT HAS ACQUIRED INTEGENX.  Full Article

OncoTherapy Science unit says business alliance with Thermo Fisher Scientific
Thursday, 15 Feb 2018 12:24am EST 

Feb 15 (Reuters) - OncoTherapy Science Inc <4564.T>:Says its unit, Cancer Precision Medicine forms business alliance with Thermo Fisher Scientific .Says two entities mainly cooperate on evaluation of liquid biopsy platform based on Ion Torrent Oncomine Pan-Cancer Cell-Free Assay .  Full Article

Juno Therapeutics And Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Wednesday, 20 Dec 2017 08:00am EST 

Dec 20 (Reuters) - Juno Therapeutics Inc ::JUNO THERAPEUTICS AND THERMO FISHER SCIENTIFIC ANNOUNCE CAR T MANUFACTURING PARTNERSHIP.JUNO THERAPEUTICS - OBTAINED RIGHTS TO USE CTS DYNABEADS CD3/CD28 MAGNETIC BEADS FOR CLINICAL, COMMERCIAL MANUFACTURING PROCESSES FOR CAR T THERAPIES.JUNO THERAPEUTICS INC - NO OTHER TERMS FROM THIS TRANSACTION WERE DISCLOSED.  Full Article

Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets From Eptek Technology
Monday, 4 Dec 2017 09:00am EST 

Dec 4 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC ACQUIRES CONTINUOUS EMISSION MONITORING ASSETS FROM EPTEK TECHNOLOGY.THERMO FISHER SCIENTIFIC INC - TERMS OF TRANSACTION WERE NOT DISCLOSED.​.  Full Article

Evoke Pharma signs commercial agreement with Thermo Fisher Scientific
Thursday, 9 Nov 2017 08:30am EST 

Nov 9 (Reuters) - Evoke Pharma Inc ::Signs commercial agreement with Thermo Fisher Scientific.Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​.Under five-year agreement, Thermo Fisher will manufacture Gimoti for Evoke's potential commercial efforts​.  Full Article

Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes
Monday, 6 Nov 2017 07:19am EST 

Nov 6 (Reuters) - Cellular Biomedicine Group Inc :Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes.Cellular Biomedicine Group Inc - ‍partnership focuses on research and development of an automated cell therapy manufacturing system​.  Full Article

Thermo Fisher enters agreement with Blueprint Medicines​
Tuesday, 31 Oct 2017 07:00am EDT 

Oct 31 (Reuters) - Thermo Fisher Scientific Inc TMO.N:Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​.Thermo Fisher Scientific - co will retain rights to commercialize test globally, to lead necessary filings to seek clearance from regulatory agencies.Thermo Fisher Scientific Inc - ‍agreement to develop and commercialize Oncomine Dx Target Test as a companion diagnostic for BLU-667​.  Full Article

BRIEF-Thermo Fisher Scientific CEO Marc Casper's FY 2017 Total Compenstion Was $22.3 Mln VS $17.8 Mln

* THERMO FISHER SCIENTIFIC CEO MARC N. CASPER'S FY 2017 TOTAL COMPENSTION WAS $22.3 MLN VS $17.8 MLN - SEC FILING Source text: (https://bit.ly/2HqYMsM) Further company coverage: